TG THERAPEUTICS, INC. (TGTX) /
The cash flow of TG THERAPEUTICS, INC. over the past 10 years
Chart TG THERAPEUTICS, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, TG THERAPEUTICS, INC.'s operating cash flow was -$24.77M and its capital expenditures $214K, leaving free cash flow of -$24.99M. Free cash flow was below zero in all 10 years shown. It ranged from -$296.04M in fiscal 2021 to -$24.99M in fiscal 2025. Capital expenditures were highest in fiscal 2021, at $401K.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$24.77M | $214K | -$24.99M |
| 2024ended Dec 31, 2024 | -$40.52M | $45K | -$40.56M |
| 2023ended Dec 31, 2023 | -$31.41M | $0 | -$31.41M |
| 2022ended Dec 31, 2022 | -$176.17M | $14K | -$176.18M |
| 2021ended Dec 31, 2021 | -$295.63M | $401K | -$296.04M |
| 2020ended Dec 31, 2020 | -$214.51M | $357K | -$214.86M |
| 2019ended Dec 31, 2019 | -$132.81M | $131K | -$132.94M |
| 2018ended Dec 31, 2018 | -$128.93M | $90K | -$129.01M |
| 2017ended Dec 31, 2017 | -$93.76M | $2K | -$93.76M |
| 2016ended Dec 31, 2016 | -$61.59M | $344K | -$61.93M |
Fiscal years as TG THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on TG THERAPEUTICS, INC.
- The revenue of TG THERAPEUTICS, INC.
- The profitability of TG THERAPEUTICS, INC.
- The debt of TG THERAPEUTICS, INC.
- All of TG THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- PRIPrimerica, Inc.
- VMIValmont Industries, Inc.
- SANMSanmina Corporation
- AOSA. O. Smith Corporation
- MORNMORNINGSTAR, INC.
Not investment advice. This page shows what TG THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.